Results 221 to 230 of about 61,348 (311)

Black Fugitivity in the Sporting Workplace: The Story of Eniola Aluko

open access: yesGender, Work &Organization, EarlyView.
ABSTRACT Being a Black fugitive involves constant movement: to find and cultivate spaces of safety and hope. In this paper, I curate a sporting archive about the UK Black women's elite football player Eniola Aluko to read her as a Black fugitive. I demonstrate how she traversed a racist and anti‐Black sporting workplace—where she was unfairly demonized
Aarti Ratna
wiley   +1 more source

Accelerometer-measured physical activity: comparing young adult football players and non-athletic peers. [PDF]

open access: yesFront Sports Act Living
Jovanovic S   +4 more
europepmc   +1 more source

Unmothered at Work: Organizational Silence Around Reproductive Loss

open access: yesGender, Work &Organization, EarlyView.
ABSTRACT An identity transition refers to changes in self‐concept that can result from professional or personal shifts. Although organizations increasingly support institutionally legible and culturally normative nonwork transitions, others remain professionally stigmatized or culturally unspeakable.
Katrina M. Brownell
wiley   +1 more source

Speaking Up and Standing Out: How Gendered Logics Shape Women's Self‐Advocacy at Work

open access: yesGender, Work &Organization, EarlyView.
ABSTRACT A widely held assumption is that women self‐advocate less than men. Our study challenges this view. Drawing on interviews with 71 men and women in a multinational company's leadership development pipeline and 10 HRM managers, we examine how women navigate self‐advocacy within gendered organizational logics.
Vedika Lal   +4 more
wiley   +1 more source

Lower-Body Muscle Volumes Can Explain Half of the Variance in Sprint Speed Between Collegiate American Football Players. [PDF]

open access: yesScand J Med Sci Sports
Martin JA   +6 more
europepmc   +1 more source

Bret/BRAT

open access: yes
Critical Quarterly, EarlyView.
Nicholas Smart
wiley   +1 more source

Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A

open access: yesHaemophilia, EarlyView.
ABSTRACT Introduction Valoctocogene roxaparvovec is an adeno‐associated virus vector serotype 5 (AAV5)‐mediated gene therapy for severe haemophilia A (HA). Aim Report the final safety and efficacy results of the phase 1/2 trial of valoctocogene roxaparvovec. Methods An open‐label phase 1/2 trial (NCT02576795) enrolled adult males with severe HA (factor
Priyanka Raheja   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy